Actavia Life Sciences, Inc.
RASP
$0.004
-$0.0285-87.69%
03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.40K | 19.20K | 75.00K | 2.50K | 2.20K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 47.20K | 7.00K | 20.70K | 34.60K | 50.10K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 48.60K | 26.20K | 95.70K | 37.10K | 52.30K |
|
|||||
Total Current Assets | 48.60K | 26.20K | 95.70K | 37.10K | 52.30K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 48.60K | 26.20K | 95.70K | 37.10K | 52.30K |
|
|||||
Total Accounts Payable | 1.50M | 1.51M | 959.70K | 1.48M | 1.47M |
Total Accrued Expenses | 420.90K | 388.60K | 878.90K | 315.40K | 236.90K |
Short-term Debt | 304.00K | 225.70K | 211.00K | 215.50K | 220.40K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.90K | 1.60K | 2.00K | -- | -- |
Total Other Current Liabilities | 1.90K | 1.60K | 2.00K | -- | -- |
Total Current Liabilities | 2.23M | 2.13M | 2.05M | 2.01M | 1.92M |
|
|||||
Total Current Liabilities | 2.23M | 2.13M | 2.05M | 2.01M | 1.92M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 304.00K | 225.70K | 211.00K | 215.50K | 220.40K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.23M | 2.13M | 2.05M | 2.01M | 1.92M |
|
|||||
Common Stock & APIC | 26.73M | 26.71M | 26.71M | 26.63M | 26.63M |
Retained Earnings | -28.91M | -28.81M | -28.66M | -28.61M | -28.50M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -2.18M | -2.10M | -1.96M | -1.98M | -1.87M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.18M | -2.10M | -1.96M | -1.98M | -1.87M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.18M | -2.10M | -1.96M | -1.98M | -1.87M |
|